Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa

Tropical Medicine and International Health

Volumn 15, Issue SUPPL. 1, 2010, Pages 34-42

  Ekouevi, Didier K ^a,b   Balestre, Eric ^a   Ba Gomis, Franck Olivier ^c   Eholie, Serge Paul ^b   Maiga, Moussa ^d   Amani Bosse, Clarisse ^e   Minga, Albert ^b,f   Messou, Eugène ^e   Sow, Papa Salif ^g   Lewden, Charlotte ^a   Traoré, Hamar Allassane ^h   Bissagnene, Emmanuel ^b   Dabis, François ^a  

^a INSERM   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

^c Centre Integrée de Recherches Bioclinique d'Abidjan   (Côte d’Ivoire)

^d HÔPITAL GABRIEL TOURÉ   (Mali)

^e ACONDA   (Côte d’Ivoire)

^f Centre Médical de Suivi de Donneurs de Sang CNTS PRIMO CI   (Côte d’Ivoire)

^g Centre Hospitalier Universitaire Dakar   (Senegal)

^h Hopital National du Point G   (Mali)

Author keywords

Cohort studies; HIV infection; Loss to follow up; Mortality; Retention; West Africa

Indexed keywords

ANTIRETROVIRUS AGENT; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COHORT ANALYSIS; CONFIDENCE INTERVAL; DISEASE TREATMENT; DRUG PRESCRIBING; EPIDEMIOLOGY; HEALTH SERVICES; HOSPITAL SECTOR; HUMAN IMMUNODEFICIENCY VIRUS; MEDICINE; NUMERICAL MODEL; PROBABILITY; PUBLIC HEALTH; WEIBULL THEORY;

ADULT; AFRICA; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DECENTRALIZATION; FEMALE; FOLLOW UP; FUNDING; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CENTER; HEALTH PROGRAM; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT MONITORING;

ADOLESCENT; ADULT; AGE FACTORS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; EPIDEMIOLOGIC METHODS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SEX FACTORS; YOUNG ADULT;

BENIN [WEST AFRICA]; COTE D'IVOIRE; GAMBIA; MALI; SENEGAL;

EID: 77951862856     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2010.02505.x     Document Type: Article

References (24)

1. Anglaret X, Toure S, Gourvellec G et al. (2004) Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from Sub-Saharan Africa. Journal of Acquired Immune Deficiency Syndrome 35, 320 323.
2. Bisson GP, Gaolathe T, Gross R et al. (2008) Overestimates of survival after HAART: implications for global scale-up efforts. PLoS ONE 3, e1725.
3. Braitstein P, Brinkhof MW, Dabis F et al. (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367, 817 824.
4. Brinkhof MW, Dabis F, Myer L et al. (2008) Early loss of HIV-infected patients on potent antiretroviral therapy programs in lower-income countries. Bulletin of the World Health Organization 86, 559 567.
5. Brinkhof MW, Pujades-Rodriguez M Egger M (2009) Mortality of patients lost to follow-up in antiretroviral treatment programs in resource-limited settings: systematic review and meta-analysis. PLoS ONE 4, e5790.
6. Calmy A, Pinoges L, Szumilin E et al. (2006) Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS 20, 1163 1169.
7. Dalal RP, Macphail C, Mqhayi M et al. (2008) Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in Johannesburg, South Africa. Journal of Acquired Immune Deficiency Syndrome 47, 101 107.
8. Etard JF, Ndiaye I, Thierry-Mieg M et al. (2006) Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal. AIDS 20, 1181 1189.
9. Giordano TP, Gifford AL, White AC et al. (2007) Retention in care: a challenge to survival with HIV infection. Clinical Infectious Diseases 44, 1493 1499.
10. Gutierez R (2002) Parametric frailty and shared frailty survival models. The Stata Journal 2, 22 44.
11. Keiding N, Andersen PK Klein JP (1997) The role of frailty models and accelerated failure time models in describing heterogeneity due to omitted covariates. Statistics in Medicine 16, 215 224.
12. Lawn SD, Harries AD, Anglaret X et al. (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22, 1897 1908.
13. Losina E, Toure H, Uhler L et al. (2008) The clinical and economic impact of interventions to prevent loss to follow-up (LTFU) in resource-limited settings. PLoS Medicine 10, e174.
14. PEPFAR (2008) U.S. President's Emergency Plan for AIDS Relief. Available at: http://www.pepfar.gov/documents/organization/115411.pdf. (accessed on 30 September 2009)
15. Rosen S, Fox MP Gill CJ (2007) Patient retention in antiretroviral therapy programs in sub-Saharan Africa. PLoS Medicine 4, e298.
16. Srasuebkul P, Lim PL, Lee MP et al. (2009) Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database. Clinical Infectious Diseases 48, 940 950.
17. Stringer JS, Zulu I, Levy J et al. (2006) Rapid scale-up of antiretroviral therapy at primary care sites in Zambia. JAMA 296, 782 793.
18. The Global Fund to fight AIDS Tuberculosis and Malaria (2008) Annual Report 2008. Available at: http://www.theglobalfund.org/documents/publications/ annualreports/2008/Annual Report2008.pdf (accessed on 30 September 2009).
19. Tonwe-Gold B, Ekouevi DK, Amani-Bosse C et al. (2009) Implementing family-focused HIV care and treatment: the first two years' experience of the MTCT-Plus program in Abidjan, Côte d'Ivoire. Tropical Medicine and International Health 14, 204 212.
20. Toure S, Kouadio B, Seyler C et al. (2008) Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cote d'Ivoire: 2-year outcomes and determinants. AIDS 22, 873 882.
21. Tsague L, Koulla S, Kenfak A et al. (2008) Determinants of retention in care in an antiretroviral therapy (ART) program in urban Cameroon. The Pan African Medical Journal 1, 1 2.
22. Weidle PJ, Malamba S, Mwebaze R et al. (2002) Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance. Lancet 360, 34 40.
23. WHO/UNAIDS/UNICEF (2008) Towards universal access. Scaling up priority HIV/AIDS interventions in the health sector. Available at: http://www.who.int/ hiv/pub/towards-universal-access-report-2008.pdf (accessed on 30 September 2009)
24. Yu JK, Chen SC, Wang KY et al. (2007) True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bulletin of the World Health Organization 85, 550 554.